首页|带蒂侧胸穿支皮瓣在保乳整形手术中的应用

带蒂侧胸穿支皮瓣在保乳整形手术中的应用

扫码查看
女性乳腺癌发现较晚,保乳术后乳房缺损大,术后容易导致乳房畸形,这是导致保乳率低的一个非常重要的因素。侧胸皮瓣作为自体皮瓣的一种,用于保乳整形术中,不失为一种实用的新型皮瓣。通过文献调研,本文总结了侧胸皮瓣应用于乳腺癌保乳整形手术的临床场景,包括乳房外上象限、外下象限、中央区的缺损修复,可采用侧胸筋膜组织瓣进行修复,若乳腺缺损组织量约占乳房总体积的20%~30%或切除腺体量在50~100 g之间,采用侧胸筋膜组织瓣进行修复较为合适。该术式可以满足女性患者对乳房美学效果的追求,恢复患者的自信,提高患者生活质量,在一定程度上扩大保乳指征,提高临床保乳率,侧胸皮瓣保乳整形术具有较高的临床应用价值,具有良好的安全性、有效性和美学效果,未来值得进一步推广。
Application of pedicled lateral perforator flap in breast conserving plastic surgery
Domestic female breast cancer is found late,the breast defect after breast preservation is large,and the postop-erative breast deformity is easy to lead to,which is a very important factor leading to the low breast preservation rate.As a kind of autologous skin flap,the lateral chest flap is a practical new flap used in breast conserving plastic surgery.Through literature research,the author summarized the clinical scenarios of the application of lateral breast flap in breast conserving plastic surgery for breast cancer,including:Lateral thoracic fascia tissue flap can be used to repair the defects in the outer upper quadrant,outer lower quadrant and central region of the breast.If the amount of breast tissue defect accounts for about 20%-30%of the total breast volume or the amount of glands removed is between 50-100 g,the lateral thoracic fascia tissue flap is more suitable for repair.The warlock can meet the female patients'pursuit of breast aesthetic effect,restore the pa-tients'confidence,improve the patients'quality of life,expand the indications of breast preservation to a certain extent,and improve the clinical breast preservation rate.The breast conserving plastic surgery with lateral chest flap has high clinical application value,with good safety,effectiveness and aesthetic effects,and is worth further promotion in the future.

Breast cancerLateral thoracic flapBreast-conserving plastic surgeryPerforator flapClinical applications

谢丽、高纪东

展开 >

国家癌症中心国家肿瘤临床医学研究中心中国医学科学院北京协和医学院肿瘤医院深圳医院乳腺外科,广东深圳 518000

乳腺癌 侧胸皮瓣 保乳整形术 穿支皮瓣 临床应用

中国医学科学院肿瘤医院深圳医院青年启动基金项目

SZ2020QN008

2024

中国当代医药
中国保健协会 当代创新(北京)医药科学研究院

中国当代医药

影响因子:1.215
ISSN:1674-4721
年,卷(期):2024.31(5)
  • 41